Christopher Higgs

961 total citations
18 papers, 687 citations indexed

About

Christopher Higgs is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Christopher Higgs has authored 18 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Molecular Biology and 5 papers in Virology. Recurrent topics in Christopher Higgs's work include HIV/AIDS drug development and treatment (7 papers), Receptor Mechanisms and Signaling (6 papers) and HIV Research and Treatment (5 papers). Christopher Higgs is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Receptor Mechanisms and Signaling (6 papers) and HIV Research and Treatment (5 papers). Christopher Higgs collaborates with scholars based in United Kingdom, United States and Denmark. Christopher Higgs's co-authors include Christopher A. Reynolds, Christopher R. Snell, Woody Sherman, Thijs Beuming, Paul R. Gouldson, R. P. Bywater, Robert P. Bywater, Richard E. Smith, Paul D. Scott and Trevor Howe and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Christopher Higgs

18 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Higgs United Kingdom 12 432 212 115 100 80 18 687
Christian Watson United States 5 554 1.3× 338 1.6× 94 0.8× 127 1.3× 85 1.1× 6 779
Per-Olof Markgren Sweden 13 631 1.5× 100 0.5× 133 1.2× 128 1.3× 169 2.1× 13 1.1k
Silvia Noiman Israel 14 486 1.1× 197 0.9× 136 1.2× 39 0.4× 18 0.2× 16 798
Chris Watson United States 9 279 0.6× 187 0.9× 44 0.4× 86 0.9× 63 0.8× 14 427
Mireia Olivella Spain 16 629 1.5× 294 1.4× 53 0.5× 30 0.3× 18 0.2× 32 833
Jean Vizzavona France 12 466 1.1× 51 0.2× 33 0.3× 134 1.3× 67 0.8× 18 741
Andy Merritt United Kingdom 15 430 1.0× 95 0.4× 172 1.5× 20 0.2× 29 0.4× 32 816
Sara E. Nichols United States 11 483 1.1× 115 0.5× 202 1.8× 23 0.2× 51 0.6× 14 603
Mark D. Yeager United States 12 497 1.2× 89 0.4× 64 0.6× 25 0.3× 23 0.3× 12 771
Bernard‐Pierre Roques France 12 353 0.8× 87 0.4× 24 0.2× 133 1.3× 70 0.9× 18 577

Countries citing papers authored by Christopher Higgs

Since Specialization
Citations

This map shows the geographic impact of Christopher Higgs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Higgs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Higgs more than expected).

Fields of papers citing papers by Christopher Higgs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Higgs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Higgs. The network helps show where Christopher Higgs may publish in the future.

Co-authorship network of co-authors of Christopher Higgs

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Higgs. A scholar is included among the top collaborators of Christopher Higgs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Higgs. Christopher Higgs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Yuqi, Márton Vass, Da Shi, et al.. (2023). Benchmarking Refined and Unrefined AlphaFold2 Structures for Hit Discovery. Journal of Chemical Information and Modeling. 63(6). 1656–1667. 64 indexed citations
2.
Jackson, Akil, Laura Else, Christopher Higgs, et al.. (2017). Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals. HIV Clinical Trials. 19(1). 31–37. 4 indexed citations
3.
Coughlin, Jennifer M., Tetsu Tanaka, Anouk Marsman, et al.. (2015). Decoupling of N-Acetyl-Aspartate and Glutamate Within the Dorsolateral Prefrontal Cortex in Schizophrenia. Current Molecular Medicine. 15(2). 176–183. 24 indexed citations
4.
Clark, David E., Christopher Higgs, Marcel J. de Groot, et al.. (2014). From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 24(9). 2212–2221. 8 indexed citations
5.
Dyke, Hazel J., Christopher Higgs, David E. Clark, et al.. (2010). Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 20(8). 2516–2519. 24 indexed citations
6.
Bergin, Philip, Dilbinder K. Gill, Hannah M. Cheeseman, et al.. (2010). Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV‐1 Vaccine Candidates. The Journal of Infectious Diseases. 201(5). 720–729. 60 indexed citations
7.
Higgs, Christopher, Thijs Beuming, & Woody Sherman. (2010). Hydration Site Thermodynamics Explain SARs for Triazolylpurines Analogues Binding to the A2A Receptor. ACS Medicinal Chemistry Letters. 1(4). 160–164. 90 indexed citations
8.
Moyle, Graeme, Christopher Higgs, Sundhiya Mandalia, et al.. (2006). An Open-Label, Randomized Comparative Pilot Study of a Single-Class Quadruple Therapy Regimen versus a 2–Class Triple Therapy Regimen for Individuals Initiating Antiretroviral Therapy. Antiviral Therapy. 11(1). 73–78. 34 indexed citations
9.
Boffito, Marta, Anton Pozniak, Brian P. Kearney, et al.. (2005). Lack of Pharmacokinetic Drug Interaction between Tenofovir Disoproxil Fumarate and Nelfinavir Mesylate. Antimicrobial Agents and Chemotherapy. 49(10). 4386–4389. 20 indexed citations
10.
Clark, David E., Christopher Higgs, Stephen P. Wren, et al.. (2004). A Virtual Screening Approach to Finding Novel and Potent Antagonists at the Melanin-Concentrating Hormone 1 Receptor. Journal of Medicinal Chemistry. 47(16). 3962–3971. 67 indexed citations
11.
Higgs, Christopher, Richard E. Smith, Robert P. Bywater, et al.. (2001). Dimerization of G-Protein-Coupled Receptors. Journal of Medicinal Chemistry. 44(26). 4595–4614. 116 indexed citations
12.
Noormohamed, Faruq H., M Youle, Christopher Higgs, et al.. (1999). Pharmacokinetics and Hemodynamic Effects of Single Oral Doses of Thalidomide in Asymptomatic Human Immunodeficiency Virus-Infected Subjects. AIDS Research and Human Retroviruses. 15(12). 1047–1052. 24 indexed citations
13.
Gkoutos, Georgios V., Christopher Higgs, Robert P. Bywater, Paul R. Gouldson, & Christopher A. Reynolds. (1999). Evidence for dimerization in the ?2-adrenergic receptor from the evolutionary trace method. International Journal of Quantum Chemistry. 74(3). 371–379. 9 indexed citations
14.
Gouldson, Paul R., Christopher R. Snell, R. P. Bywater, Christopher Higgs, & Christopher A. Reynolds. (1998). Domain swapping in G-protein coupled receptor dimers. Protein Engineering Design and Selection. 11(12). 1181–1193. 111 indexed citations
15.
Noormohamed, Faruq H., M Youle, Christopher Higgs, et al.. (1998). Pharmacokinetics and Absolute Bioavailability of Oral Foscarnet in Human Immunodeficiency Virus-Seropositive Patients. Antimicrobial Agents and Chemotherapy. 42(2). 293–297. 16 indexed citations
16.
Youle, M, et al.. (1997). Renal excretion and pharmacokinetics of foscarnet in HIV sero-positive patients: effect of probenecid pretreatment. British Journal of Clinical Pharmacology. 43(1). 112–115. 7 indexed citations
17.
Youle, M, et al.. (1997). Renal excretion and pharmacokinetics of foscarnet in HIV sero‐positive patients: effect of probenecid pretreatment. British Journal of Clinical Pharmacology. 43(1). 112–115. 2 indexed citations
18.
Cambie, RC, et al.. (1995). Experiments Directed Towards the Synthesis of Anthracyclinones. XXVII. Transformations of 2,3-Bisalkynyl and 2,3-Bisalkenyl Anthraquinones. Australian Journal of Chemistry. 48(6). 1089–1106. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Watson Breakdown of academic impact, for papers by Per-Olof Markgren Breakdown of academic impact, for papers by Silvia Noiman Breakdown of academic impact, for papers by Chris Watson Breakdown of academic impact, for papers by Mireia Olivella Breakdown of academic impact, for papers by Jean Vizzavona Breakdown of academic impact, for papers by Andy Merritt Breakdown of academic impact, for papers by Sara E. Nichols Breakdown of academic impact, for papers by Mark D. Yeager Breakdown of academic impact, for papers by Bernard‐Pierre Roques
Rankless by CCL
2026